-
From next year, these drugs will no longer be reimbursed by Medicare pharmacies
Time of Update: 2021-03-07
, Jiangsu Provincial Medical Security Bureau, Jiangsu Provincial Human Resources and Social Security Department jointly issued "on the publication of basic medical insurance, work injury insurance and
-
Methods for the Pasteurella Glycosaminoglycan Synthases: Enzymes that Polymerize Hyaluronan, Chondroitin, or Heparosan Chains
Time of Update: 2020-12-23
Multiple glycosyltransferases (GTases) that produce glycosaminoglycans (GAGs) have been identified; �several distinct putative architectures and catalytic abilities have been noted from microbes and vertebrates.
The related Chapter 18 is focused on larger molecular weight GAGs analyses as well as the Class I membrane streptococcal and mammalian HA synthases.
-
Clinical Trends of China's Class 1 New Drugs in May 2020
Time of Update: 2020-08-01
In May 2020, a total of 19 Chinese class 1 chemical drugs were approved by the State Drug Administration (NMPA) for clinical trials, the specific information is shown in the table below: data sources: Pharmaceutical Spyu Database01, SPH4336 SPH-4336 developed by Shanghai Pharmaceuticals, in the clinical phase of the treatment of advanced solid tumors.
-
Who is the biggest winner of Fujian bidding scheme
Time of Update: 2014-10-08
Source: on the last day of medical cloud information and sabilan 2014-10-08 September, Fujian Province finally released the implementation plan for 2014 centralized drug procurement of medical institu
